-
2
-
-
33745150754
-
Role of angiotensin II in cardiovascular disease - Therapeutic implications of more than a century of research
-
Ferrario CM. Role of angiotensin II in cardiovascular disease therapeutic implications of more than a century of research. J Renin Angiotensin Aldosterone Syst. 2006;7(1):3-14. (Pubitemid 43891239)
-
(2006)
JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
, vol.7
, Issue.1
, pp. 3-14
-
-
Ferrario, C.M.1
-
3
-
-
74949092226
-
New physiological concepts of the renin-angiotensin system from the investigation of precursors and products of angiotensin I metabolism
-
Ferrario CM. New physiological concepts of the renin-angiotensin system from the investigation of precursors and products of angiotensin I metabolism. Hypertension. 2010;55(2):445-52.
-
(2010)
Hypertension
, vol.55
, Issue.2
, pp. 445-452
-
-
Ferrario, C.M.1
-
4
-
-
0000254274
-
Release of vaso-pressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide
-
Schiavone MT, Santos RA, Brosnihan KB, et al. Release of vaso-pressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide. Proc Natl Acad Sci U S A. 1988;85(11):4095-8.
-
(1988)
Proc Natl Acad Sci U S A
, vol.85
, Issue.11
, pp. 4095-4098
-
-
Schiavone, M.T.1
Santos, R.A.2
Brosnihan, K.B.3
-
5
-
-
84891403514
-
An evolving story of angiotensin-II-forming pathways in rodents and humans
-
Ferrario CM, Ahmad S, Nagata S, et al. An evolving story of angiotensin-II-forming pathways in rodents and humans. Clin Sci (Lond). 2014;126(7):461-9.
-
(2014)
Clin Sci (Lond)
, vol.126
, Issue.7
, pp. 461-469
-
-
Ferrario, C.M.1
Ahmad, S.2
Nagata, S.3
-
6
-
-
28144445338
-
Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function
-
DOI 10.1152/ajpheart.00618.2005
-
Ferrario CM, Trask AJ, Jessup JA. Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function. Am J Physiol Heart Circ Physiol. 2005;289(6):H2281-90. (Pubitemid 41698533)
-
(2005)
American Journal of Physiology - Heart and Circulatory Physiology
, vol.289
, Issue.6
-
-
Ferrario, C.M.1
Trask, A.J.2
Jessup, J.A.3
-
7
-
-
33644970894
-
Angiotensin-converting enzyme 2 and angiotensin-(1-7): An evolving story in cardiovascular regulation
-
DOI 10.1161/01.HYP.0000196268.08909.fb
-
Ferrario CM. Angiotensin-converting enzyme 2 and angiotensin-(1-7): an evolving story in cardiovascular regulation. Hypertension. 2006;47(3):515-21. (Pubitemid 43843868)
-
(2006)
Hypertension
, vol.47
, Issue.3 II
, pp. 515-521
-
-
Ferrario, C.M.1
-
8
-
-
77952689893
-
The ANG-(1-7)/ACE2/mas axis in the regulation of nephron function
-
Ferrario CM, Varagic J. The ANG-(1-7)/ACE2/mas axis in the regulation of nephron function. Am J Physiol Renal Physiol. 2010;298(6):F1297-305.
-
(2010)
Am J Physiol Renal Physiol
, vol.298
, Issue.6
-
-
Ferrario, C.M.1
Varagic, J.2
-
9
-
-
84872617624
-
Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: New players of the renin-angiotensin system
-
Santos RA, Ferreira AJ, Verano-Braga T, et al. Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system. J Endocrinol. 2013;216(2):R1-17.
-
(2013)
J Endocrinol
, vol.216
, Issue.2
-
-
Santos, R.A.1
Ferreira, A.J.2
Verano-Braga, T.3
-
10
-
-
33745845825
-
Physiology of local renin-angiotensin systems
-
DOI 10.1152/physrev.00036.2005
-
Paul M, Poyan MA, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev. 2006;86(3):747-803. (Pubitemid 44033382)
-
(2006)
Physiological Reviews
, vol.86
, Issue.3
, pp. 747-803
-
-
Paul, M.1
Mehr, A.P.2
Kreutz, R.3
-
11
-
-
6344246036
-
Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism
-
DOI 10.1042/BJ20040634
-
Rice GI, Thomas DA, Grant PJ, et al. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J. 2004;383(Pt 1):45-51. (Pubitemid 39389449)
-
(2004)
Biochemical Journal
, vol.383
, Issue.1
, pp. 45-51
-
-
Rice, G.I.1
Thomas, D.A.2
Grant, P.J.3
Turner, A.J.4
Hooper, N.M.5
-
12
-
-
33750264733
-
Circulating activities of angiotensin-converting enzyme, its homolog, angiotensin-converting enzyme 2, and neprilysin in a family study
-
DOI 10.1161/01.HYP.0000244543.91937.79, PII 0000426820061100000026
-
Rice GI, Jones AL, Grant PJ, et al. Circulating activities of angiotensin-converting enzyme, its homolog, angiotensin-converting enzyme 2, and neprilysin in a family study. Hypertension. 2006;48(5):914-20. (Pubitemid 44611005)
-
(2006)
Hypertension
, vol.48
, Issue.5
, pp. 914-920
-
-
Rice, G.I.1
Jones, A.L.2
Grant, P.J.3
Carter, A.M.4
Turner, A.J.5
Hooper, N.M.6
-
13
-
-
18244407290
-
2 receptor comes of age
-
DOI 10.1161/01.HYP.0000159192.93968.8f
-
Carey RM. Cardiovascular and renal regulation by the angiotensin type 2 receptor: the AT2 receptor comes of age. Hypertension. 2005;45(5):840-4. (Pubitemid 40628923)
-
(2005)
Hypertension
, vol.45
, Issue.5
, pp. 840-844
-
-
Carey, R.M.1
-
14
-
-
84886406732
-
Newly discovered components and actions of the renin-angiotensin system
-
This review article provides a timely perspective of the components and actions of the renin angiotensin system, including receptor mechanisms
-
• Carey RM. Newly discovered components and actions of the renin-angiotensin system. Hypertension. 2013;62(5):818-22. This review article provides a timely perspective of the components and actions of the renin angiotensin system, including receptor mechanisms.
-
(2013)
Hypertension
, vol.62
, Issue.5
, pp. 818-822
-
-
Carey, R.M.1
-
15
-
-
84881001924
-
Role of angiotensin AT(2) receptors in natriuresis: Intrarenal mechanisms and therapeutic potential
-
Carey RM, Padia SH. Role of angiotensin AT(2) receptors in natriuresis: Intrarenal mechanisms and therapeutic potential. Clin Exp Pharmacol Physiol. 2013;40(8):527-34.
-
(2013)
Clin Exp Pharmacol Physiol
, vol.40
, Issue.8
, pp. 527-534
-
-
Carey, R.M.1
Padia, S.H.2
-
16
-
-
84876407858
-
Discovery and characterization of alamandine: A novel component of the renin-angiotensin system
-
Biological effects are demonstrated for an heptapeptide where the sequence of Ang-(1-7) is modified at the N-terminus by the substitution of aspartic by alanine in position 1. The heptapeptide has a preference for the Mas-related G-protein-coupled receptor, member D
-
• Lautner RQ, Villela DC, Fraga-Silva RA, et al. Discovery and characterization of alamandine: a novel component of the renin-angiotensin system. Circ Res. 2013;112(8):1104-11. Biological effects are demonstrated for an heptapeptide where the sequence of Ang-(1-7) is modified at the N-terminus by the substitution of aspartic by alanine in position 1. The heptapeptide has a preference for the Mas-related G-protein-coupled receptor, member D.
-
(2013)
Circ Res
, vol.112
, Issue.8
, pp. 1104-1111
-
-
Lautner, R.Q.1
Villela, D.C.2
Fraga-Silva, R.A.3
-
18
-
-
84871596560
-
Regulation of cardiovascular remodeling by the counter-regulatory axis of the renin-angiotensin system
-
Clarke C, Flores-Munoz M, McKinney CA, et al. Regulation of cardiovascular remodeling by the counter-regulatory axis of the renin-angiotensin system. Futur Cardiol. 2013;9(1):23-38.
-
(2013)
Futur Cardiol
, vol.9
, Issue.1
, pp. 23-38
-
-
Clarke, C.1
Flores-Munoz, M.2
McKinney, C.A.3
-
19
-
-
84866697003
-
Adenoviral delivery of angiotensin-(1-7) or angiotensin-(1-9) inhibits cardiomyocyte hypertrophy via the mas or angiotensin type 2 receptor
-
Flores-Munoz M, Godinho BM, Almalik A, et al. Adenoviral delivery of angiotensin-(1-7) or angiotensin-(1-9) inhibits cardiomyocyte hypertrophy via the mas or angiotensin type 2 receptor. PLoS One. 2012;7(9):e45564.
-
(2012)
PLoS One
, vol.7
, Issue.9
-
-
Flores-Munoz, M.1
Godinho, B.M.2
Almalik, A.3
-
20
-
-
84896315328
-
Angiotensin-(1-9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme/Ang II axis
-
Ocaranza MP, Moya J, Barrientos V et al. Angiotensin-(1-9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme/Ang II axis. J Hypertens 2014.
-
(2014)
J Hypertens
-
-
Ocaranza, M.P.1
Moya, J.2
Barrientos, V.3
-
21
-
-
44349101152
-
Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger people: Meta-analysis of randomised trials
-
DOI 10.1136/bmj.39548.738368.BE
-
Turnbull F, Neal B, Ninomiya T, et al. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ. 2008;336(7653):1121-3. (Pubitemid 351731743)
-
(2008)
BMJ
, vol.336
, Issue.7653
, pp. 1121-1123
-
-
Turnbull, F.1
-
22
-
-
84857784284
-
Systematic review and meta-analysis: Renin-Angiotensin system inhibitors in the prevention of atrial fibrillation recurrences: An unfulfilled hope
-
Disertori M, Barlera S, Staszewsky L, et al. Systematic review and meta-analysis: renin-Angiotensin system inhibitors in the prevention of atrial fibrillation recurrences: an unfulfilled hope. Cardiovasc Drugs Ther. 2012;26(1):47-54.
-
(2012)
Cardiovasc Drugs Ther
, vol.26
, Issue.1
, pp. 47-54
-
-
Disertori, M.1
Barlera, S.2
Staszewsky, L.3
-
23
-
-
34147116836
-
Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system
-
DOI 10.1097/HJH.0b013e3280bad9b4, PII 0000487220070500000010
-
Turnbull F, Neal B, Pfeffer M, et al. Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system. J Hypertens. 2007;25(5):951-8. (Pubitemid 46573113)
-
(2007)
Journal of Hypertension
, vol.25
, Issue.5
, pp. 951-958
-
-
Agodoa, L.1
Anderson, C.2
Asseibergs, F.3
Baigent, C.4
Black, H.5
Brenner, B.6
Brown, M.7
Bulpitt, C.8
Byington, R.9
Chalmers, J.10
Collins, R.11
Cutler, J.12
Dahlof, B.13
Davis, B.14
De Zeeuw, D.15
Dens, J.16
Estacio, R.17
Fagard, R.18
Fox, K.19
Fukui, T.20
Hansson, L.21
Holman, R.22
Hunsicker, L.23
Imai, Y.24
Ishii, M.25
Kanno, Y.26
Kostis, J.27
Kuramoto, K.28
Lewis, E.29
Lievre, M.30
Lindholm, L.H.31
Liu, L.32
Lubsen, J.33
Lueders, S.34
MacMahon, S.35
Malacco, E.36
Mancia, G.37
Matsuzaki, M.38
Neal, B.39
Nissen, S.40
Ohkubo, T.41
Ogihara, T.42
Pepine, C.43
Pfeffer, M.44
Pitt, B.45
Poole-Wilson, P.46
Rahman, M.47
Remme, W.48
Remuzzi, G.49
Rodgers, A.50
Ruggenenti, P.51
Saruta, T.52
Schrader, J.53
Schrier, R.54
Sever, P.55
Sleight, P.56
Staessen, J.57
Teo, K.58
Viberti, G.59
Wang, J.60
Whelton, P.61
Wing, L.62
Yui, Y.63
Yusuf, S.64
Zanchetti, A.65
Turnbull, F.66
Neal, B.67
Pfeffer, M.68
Kostis, J.69
Algert, C.70
Woodward, M.71
Chalmers, J.72
Zanchetti, A.73
MacMahon, S.74
more..
-
24
-
-
44449101233
-
Étude clinique du mois. ONTARGET: Protection comparable du telmisartan et du ramipril et absence de bénéfice de la combinaison chez des patients a haut risque vasculaire
-
Scheen AJ, Krzesinski JM. ONTARGET: similar protection of telmisartan and ramipril and lack of benefit of combined therapy in patients at high risk for vascular events. Rev Med Liege. 2008;63(4):213-9. (Pubitemid 351766608)
-
(2008)
Revue Medicale de Liege
, vol.63
, Issue.4
, pp. 213-219
-
-
Scheen, A.J.1
Krzesinski, J.M.2
-
25
-
-
42049107348
-
Telmisartan, ramipril, or both in patients at high risk for vascular events
-
DOI 10.1056/NEJMoa0801317
-
Yusuf S, Teo KK, Pogue J, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358(15):1547-59. (Pubitemid 351522739)
-
(2008)
New England Journal of Medicine
, vol.358
, Issue.15
, pp. 1547-1559
-
-
Yusuf, S.1
Teo, K.K.2
Pogue, J.3
Dyal, L.4
Copland, I.5
Schumacher, H.6
Dagenais, G.7
Sleight, P.8
Anderson, C.9
-
26
-
-
84873737622
-
ALTITUDE trial and dual RAS blockade: The alluring but soft science of the surrogate end point
-
Messerli FH, Bangalore S. ALTITUDE trial and dual RAS blockade: the alluring but soft science of the surrogate end point. Am J Med. 2013;126(3):e1-3.
-
(2013)
Am J Med
, vol.126
, Issue.3
-
-
Messerli, F.H.1
Bangalore, S.2
-
27
-
-
84874025509
-
Hypotension and ischaemic stroke associated with aliskiren in the ALTITUDE trial: Sensitisation of the Bezold-Jarisch reflex?
-
Sever P. Hypotension and ischaemic stroke associated with aliskiren in the ALTITUDE trial: sensitisation of the Bezold-Jarisch reflex? J Renin Angiotensin Aldosterone Syst. 2013;14(1):1-2.
-
(2013)
J Renin Angiotensin Aldosterone Syst
, vol.14
, Issue.1
, pp. 1-2
-
-
Sever, P.1
-
28
-
-
35348976721
-
Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction: A quantitative review of data from randomized clinical trials
-
DOI 10.1001/archinte.167.18.1930
-
Phillips CO, Kashani A, Ko DK, et al. Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction: a quantitative review of data from randomized clinical trials. Arch Intern Med. 2007;167(18):1930-6. (Pubitemid 47606631)
-
(2007)
Archives of Internal Medicine
, vol.167
, Issue.18
, pp. 1930-1936
-
-
Phillips, C.O.1
Kashani, A.2
Ko, D.K.3
Francis, G.4
Krumholz, H.M.5
-
29
-
-
84888845216
-
Big angiotensin-25: A novel glycosylated angiotensin-related peptide isolated fromhuman urine
-
By screening human urine gel filtration fractions for bioactive peptides using an antibody raised against the N-terminal portion of Ang II, these investigators discovered the existence of an extended form of Ang I consisting of the first 25 amino acids of the angiotensinogen molecule. Ang-(1-25) is expressed in most human tissues and it is cleaved into Ang II by chymase. The demonstration that Ang-(1-25) is N-glycosylated on its 14th amino acid (Asn) and has a cysteine linked to its 18th amino acid (Cys) is used as evidence that the peptide is expressed in humans but not rodents
-
•• Nagata S, Hatakeyama K, Asami M, et al. Big angiotensin-25: A novel glycosylated angiotensin-related peptide isolated fromhuman urine. Biochem Biophys Res Commun. 2013;441(4):757-62. By screening human urine gel filtration fractions for bioactive peptides using an antibody raised against the N-terminal portion of Ang II, these investigators discovered the existence of an extended form of Ang I consisting of the first 25 amino acids of the angiotensinogen molecule. Ang-(1-25) is expressed in most human tissues and it is cleaved into Ang II by chymase. The demonstration that Ang-(1-25) is N-glycosylated on its 14th amino acid (Asn) and has a cysteine linked to its 18th amino acid (Cys) is used as evidence that the peptide is expressed in humans but not rodents.
-
(2013)
Biochem Biophys Res Commun
, vol.441
, Issue.4
, pp. 757-762
-
-
Nagata, S.1
Hatakeyama, K.2
Asami, M.3
-
30
-
-
33750147612
-
Isolation and identification of proangiotensin-12, a possible component of the renin-angiotensin system
-
DOI 10.1016/j.bbrc.2006.09.146, PII S0006291X06022030
-
Nagata S, Kato J, Sasaki K, et al. Isolation and identification of proangiotensin-12, a possible component of the renin-angiotensin system. Biochem Biophys Res Commun. 2006;350(4):1026-31. (Pubitemid 44596223)
-
(2006)
Biochemical and Biophysical Research Communications
, vol.350
, Issue.4
, pp. 1026-1031
-
-
Nagata, S.1
Kato, J.2
Sasaki, K.3
Minamino, N.4
Eto, T.5
Kitamura, K.6
-
31
-
-
49249116079
-
Localization of the novel angiotensin peptide, angiotensin-(1-12), in heart and kidney of hypertensive and normotensive rats
-
Jessup JA, Trask AJ, Chappell MC, et al. Localization of the novel angiotensin peptide, angiotensin-(1-12), in heart and kidney of hypertensive and normotensive rats. Am J Physiol Heart Circ Physiol. 2008;294(6):H2614-8.
-
(2008)
Am J Physiol Heart Circ Physiol
, vol.294
, Issue.6
-
-
Jessup, J.A.1
Trask, A.J.2
Chappell, M.C.3
-
32
-
-
84860488872
-
Effects of proangiotensin-12 infused continuously over 14 days in conscious rats
-
This well conducted study shows that Ang-(1-12) has long-term pressor activity, a finding that suggest that this extended form of Ang I is able to generate Ang II endogenously
-
• Komatsu Y, Kida N, Nozaki N, et al. Effects of proangiotensin-12 infused continuously over 14 days in conscious rats. Eur J Pharmacol. 2012;683(1-3):186-9. This well conducted study shows that Ang-(1-12) has long-term pressor activity, a finding that suggest that this extended form of Ang I is able to generate Ang II endogenously.
-
(2012)
Eur J Pharmacol
, vol.683
, Issue.1-3
, pp. 186-189
-
-
Komatsu, Y.1
Kida, N.2
Nozaki, N.3
-
33
-
-
67650081011
-
Chronic immunoneutralization of brain angiotensin-(1-12) lowers blood pressure in transgenic (mRen2)27 hypertensive rats
-
Isa K, Garcia-Espinosa MA, Arnold AC, et al. Chronic immunoneutralization of brain angiotensin-(1-12) lowers blood pressure in transgenic (mRen2)27 hypertensive rats. Am J Physiol Regul Integr Comp Physiol. 2009;297(1):R111-5.
-
(2009)
Am J Physiol Regul Integr Comp Physiol
, vol.297
, Issue.1
-
-
Isa, K.1
Garcia-Espinosa, M.A.2
Arnold, A.C.3
-
34
-
-
77956671617
-
Angiotensin-(1-12) requires angiotensin converting enzyme and AT1 receptors for cardiovascular actions within the solitary tract nucleus
-
Arnold AC, Isa K, Shaltout HA, et al. Angiotensin-(1-12) requires angiotensin converting enzyme and AT1 receptors for cardiovascular actions within the solitary tract nucleus. Am J Physiol Heart Circ Physiol. 2010;299(3):H763-71.
-
(2010)
Am J Physiol Heart Circ Physiol
, vol.299
, Issue.3
-
-
Arnold, A.C.1
Isa, K.2
Shaltout, H.A.3
-
35
-
-
78651318031
-
Cardiovascular responses elicited by a new endogenous angiotensin in the nucleus tractus solitarius of the rat
-
Chitravanshi VC, Sapru HN. Cardiovascular responses elicited by a new endogenous angiotensin in the nucleus tractus solitarius of the rat. Am J Physiol Heart Circ Physiol. 2011;300(1):H230-40.
-
(2011)
Am J Physiol Heart Circ Physiol
, vol.300
, Issue.1
-
-
Chitravanshi, V.C.1
Sapru, H.N.2
-
36
-
-
84865549994
-
Cardiovascular actions of angiotensin-(1-12) in the hypothalamic paraventricular nucleus of the rat are mediated via angiotensin II
-
Chitravanshi VC, Proddutur A, Sapru HN. Cardiovascular actions of angiotensin-(1-12) in the hypothalamic paraventricular nucleus of the rat are mediated via angiotensin II. Exp Physiol. 2012;97(9):1001-17.
-
(2012)
Exp Physiol
, vol.97
, Issue.9
, pp. 1001-1017
-
-
Chitravanshi, V.C.1
Proddutur, A.2
Sapru, H.N.3
-
37
-
-
79955069043
-
The hypothalamic arcuate nucleus: A new site of cardiovascular action of angiotensin-(1-12) and angiotensin II
-
Arakawa H, Chitravanshi VC, Sapru HN. The hypothalamic arcuate nucleus: a new site of cardiovascular action of angiotensin-(1-12) and angiotensin II. Am J Physiol Heart Circ Physiol. 2011;300(3):H951-60.
-
(2011)
Am J Physiol Heart Circ Physiol
, vol.300
, Issue.3
-
-
Arakawa, H.1
Chitravanshi, V.C.2
Sapru, H.N.3
-
38
-
-
84872178864
-
Angiotensin-(1-12) in the rostral ventrolateral medullary pressor area of the rat elicits sympathoexcitatory responses
-
Extending the series of studies showing Ang-(1-12) biological effects in brain nuclei influencing the brain regulation of blood pressure, these investigators describe that Ang-(1-12) elicits pressor response associated with increased splachnic nerve sympathetic discharges during microinjections of the peptide in this critical region of the rostral medulla oblongata. Adding weight to the dual role of ACE and chymase, the investigators showed that both enzymes are required for Ang-(1-12) metabolism into Ang II
-
• Arakawa H, Kawabe K, Sapru HN. Angiotensin-(1-12) in the rostral ventrolateral medullary pressor area of the rat elicits sympathoexcitatory responses. Exp Physiol. 2013;98(1):94-108. Extending the series of studies showing Ang-(1-12) biological effects in brain nuclei influencing the brain regulation of blood pressure, these investigators describe that Ang-(1-12) elicits pressor response associated with increased splachnic nerve sympathetic discharges during microinjections of the peptide in this critical region of the rostral medulla oblongata. Adding weight to the dual role of ACE and chymase, the investigators showed that both enzymes are required for Ang-(1-12) metabolism into Ang II.
-
(2013)
Exp Physiol
, vol.98
, Issue.1
, pp. 94-108
-
-
Arakawa, H.1
Kawabe, K.2
Sapru, H.N.3
-
39
-
-
62349100153
-
Cardiac chymase converts rat proAngiotensin-12 (PA12) to angiotensin II: Effects of PA12 upon cardiac haemodynamics
-
Prosser HC, Forster ME, Richards AM, et al. Cardiac chymase converts rat proAngiotensin-12 (PA12) to angiotensin II: effects of PA12 upon cardiac haemodynamics. Cardiovasc Res. 2009;82(1):40-50.
-
(2009)
Cardiovasc Res
, vol.82
, Issue.1
, pp. 40-50
-
-
Prosser, H.C.1
Forster, M.E.2
Richards, A.M.3
-
40
-
-
78249238801
-
Regional vascular response to ProAngiotensin-12 (PA12) through the rat arterial system
-
Prosser HC, Richards AM, Forster ME, et al. Regional vascular response to ProAngiotensin-12 (PA12) through the rat arterial system. Peptides. 2010;31(8):1540-5.
-
(2010)
Peptides
, vol.31
, Issue.8
, pp. 1540-1545
-
-
Prosser, H.C.1
Richards, A.M.2
Forster, M.E.3
-
41
-
-
84883435375
-
Primacy of angiotensin converting enzyme in angiotensin-(1-12) metabolism
-
Moniwa N, Varagic J, Simington SW, et al. Primacy of angiotensin converting enzyme in angiotensin-(1-12) metabolism. Am J Physiol Heart Circ Physiol. 2013;305(5):H644-50.
-
(2013)
Am J Physiol Heart Circ Physiol
, vol.305
, Issue.5
-
-
Moniwa, N.1
Varagic, J.2
Simington, S.W.3
-
42
-
-
79251592234
-
Uptake and metabolism of the novel peptide angiotensin-(1-12) by neonatal cardiac myocytes
-
This study represents the first publication that identifies Ang-(1-12) metabolic pathways in cardiac myocytes and shows increased Ang-(1-12) uptake in SHR compared with WKY
-
• Ahmad S, Varagic J, Westwood BM, et al. Uptake and metabolism of the novel peptide angiotensin-(1-12) by neonatal cardiac myocytes. PLoS One. 2011;6(1):e15759. This study represents the first publication that identifies Ang-(1-12) metabolic pathways in cardiac myocytes and shows increased Ang-(1-12) uptake in SHR compared with WKY.
-
(2011)
PLoS One
, vol.6
, Issue.1
-
-
Ahmad, S.1
Varagic, J.2
Westwood, B.M.3
-
43
-
-
84861183922
-
Divergent pathways for the angiotensin-(1-12) metabolism in the rat circulation and kidney
-
Westwood BM, Chappell MC. Divergent pathways for the angiotensin-(1-12) metabolism in the rat circulation and kidney. Peptides. 2012;35(2):190-5.
-
(2012)
Peptides
, vol.35
, Issue.2
, pp. 190-195
-
-
Westwood, B.M.1
Chappell, M.C.2
-
44
-
-
0034685637
-
Neprilysin II: A putative novel metalloprotease and its isoforms in CNS and testis
-
DOI 10.1006/bbrc.2000.2664
-
Ouimet T, Facchinetti P, Rose C, et al. Neprilysin II: A putative novel metalloprotease and its isoforms in CNS and testis. Biochem Biophys Res Commun. 2000;271(3):565-70. (Pubitemid 30444668)
-
(2000)
Biochemical and Biophysical Research Communications
, vol.271
, Issue.3
, pp. 565-570
-
-
Tanja, O.1
Facchinetti, P.2
Rose, C.3
Bonhomme, M.-C.4
Gros, C.5
Schwartz, J.-C.6
-
45
-
-
84876588807
-
Predominance of AT(1) blockade over mas-mediated angiotensin-(1-7) mechanisms in the regulation of blood pressure and renin-angiotensin system in mRen2.Lewis rats
-
While the focus of this study is on the potential contribution of the ACE2/Ang-(1-7)/mas-axis to the antihypertensive actions of the AT1-receptor antagonist, olmesartan, Table 2 documents that renal neprilysin activity is greater than 95-fold above those measured for renal ACE activity in a transgenic model of renin-dependent hypertension
-
• Varagic J, Ahmad S, Voncannon JL, et al. Predominance of AT(1) blockade over mas-mediated angiotensin-(1-7) mechanisms in the regulation of blood pressure and renin-angiotensin system in mRen2.Lewis rats. Am J Hypertens. 2013;26(5):583-90. While the focus of this study is on the potential contribution of the ACE2/Ang-(1-7)/mas-axis to the antihypertensive actions of the AT1-receptor antagonist, olmesartan, Table 2 documents that renal neprilysin activity is greater than 95-fold above those measured for renal ACE activity in a transgenic model of renin-dependent hypertension.
-
(2013)
Am J Hypertens
, vol.26
, Issue.5
, pp. 583-590
-
-
Varagic, J.1
Ahmad, S.2
Voncannon, J.L.3
-
46
-
-
84857888402
-
Lessons from in vitro studies and a related intracellular angiotensin II transgenic mouse model
-
Cook JL, Re RN. Lessons from in vitro studies and a related intracellular angiotensin II transgenic mouse model. Am J Physiol Regul Integr Comp Physiol. 2012;302(5):R482-93.
-
(2012)
Am J Physiol Regul Integr Comp Physiol
, vol.302
, Issue.5
-
-
Cook, J.L.1
Re, R.N.2
-
47
-
-
0742287703
-
Tissue renin angiotensin systems
-
DOI 10.1016/S0025-7125(03)00124-X
-
Re RN. Tissue renin angiotensin systems. Med Clin North Am. 2004;88(1):19-38. (Pubitemid 38160940)
-
(2004)
Medical Clinics of North America
, vol.88
, Issue.1
, pp. 19-38
-
-
Re, R.N.1
-
48
-
-
81255157608
-
Noncanonical intracrine action
-
A strong position paper detailing the biological significance of intracrine mechanisms in health and disease from one of the major leaders in this field
-
• Re RN, Cook JL. Noncanonical intracrine action. J Am Soc Hypertens. 2011;5(6):435-48. A strong position paper detailing the biological significance of intracrine mechanisms in health and disease from one of the major leaders in this field.
-
(2011)
J Am Soc Hypertens
, vol.5
, Issue.6
, pp. 435-448
-
-
Re, R.N.1
Cook, J.L.2
-
49
-
-
34250740891
-
The intracellular renin-angiotensin system: A new paradigm
-
DOI 10.1016/j.tem.2007.05.001, PII S1043276007000707
-
Kumar R, Singh VP, Baker KM. The intracellular renin-angiotensin system: a new paradigm. Trends Endocrinol Metab. 2007;18(5):208-14. (Pubitemid 46962301)
-
(2007)
Trends in Endocrinology and Metabolism
, vol.18
, Issue.5
, pp. 208-214
-
-
Kumar, R.1
Singh, V.P.2
Baker, K.M.3
-
50
-
-
39149119226
-
The intracellular renin-angiotensin system: Implications in cardiovascular remodeling
-
DOI 10.1097/MNH.0b013e3282f521a8, PII 0004155220080300000009
-
Kumar R, Singh VP, Baker KM. The intracellular renin-angiotensin system: implications in cardiovascular remodeling. Curr Opin Nephrol Hypertens. 2008;17(2):168-73. (Pubitemid 351253042)
-
(2008)
Current Opinion in Nephrology and Hypertension
, vol.17
, Issue.2
, pp. 168-173
-
-
Kumar, R.1
Singh, V.P.2
Baker, K.M.3
-
51
-
-
62549157381
-
The intracellular renin-angiotensin system in the heart
-
Kumar R, Singh VP, Baker KM. The intracellular renin-angiotensin system in the heart. Curr Hypertens Rep. 2009;11(2):104-10.
-
(2009)
Curr Hypertens Rep
, vol.11
, Issue.2
, pp. 104-110
-
-
Kumar, R.1
Singh, V.P.2
Baker, K.M.3
-
52
-
-
0033215367
-
The cardiac renin-angiotensin system: Conceptual, or a regulator of cardiac function?
-
Dostal DE, Baker KM. The cardiac renin-angiotensin system: conceptual, or a regulator of cardiac function? Circ Res. 1999;85(7):643-50. (Pubitemid 29467853)
-
(1999)
Circulation Research
, vol.85
, Issue.7
, pp. 643-650
-
-
Dostal, D.E.1
Baker, K.M.2
-
53
-
-
80051545369
-
On the local cardiac renin angiotensin system. Basic and clinical implications
-
De Mello WC, Frohlich ED. On the local cardiac renin angiotensin system. Basic and clinical implications. Peptides. 2011;32(8):1774-9.
-
(2011)
Peptides
, vol.32
, Issue.8
, pp. 1774-1779
-
-
De Mello, W.C.1
Frohlich, E.D.2
-
54
-
-
84870464616
-
Mechanical stretch reduces the effect of angiotensin II on potassium current in cardiac ventricular cells of adult Sprague Dawley rats. On the role of AT1 receptors asmechanosensors
-
This important paper reviews De Mello original studies showing that AT1 receptors functioning as mechanoreceptors sensing changes in cell volume can become a major source for cardiac arrhythmias
-
• De Mello WC. Mechanical stretch reduces the effect of angiotensin II on potassium current in cardiac ventricular cells of adult Sprague Dawley rats. On the role of AT1 receptors asmechanosensors. J Am Soc Hypertens. 2012;6(6):369-74. This important paper reviews De Mello original studies showing that AT1 receptors functioning as mechanoreceptors sensing changes in cell volume can become a major source for cardiac arrhythmias.
-
(2012)
J Am Soc Hypertens
, vol.6
, Issue.6
, pp. 369-374
-
-
De Mello, W.C.1
-
55
-
-
0029587599
-
Increased ACE and chymase-like activity in cardiac tissue of dogs with chronic mitral regurgitation
-
Dell'Italia LJ, Meng QC, Balcells E, et al. Increased ACE and chymase-like activity in cardiac tissue of dogs with chronic mitral regurgitation. Am J Physiol. 1995;269(6 Pt 2):H2065-73. (Pubitemid 26023225)
-
(1995)
American Journal of Physiology - Heart and Circulatory Physiology
, vol.269
, Issue.6
-
-
Dell'Italia, L.J.1
Meng, Q.C.2
Balcells, E.3
Straeter-Knowlen, I.M.4
Hankes, G.H.5
Dillon, R.6
Cartee, R.E.7
Orr, R.8
Bishop, S.P.9
Oparil, S.10
Elton, T.S.11
-
56
-
-
76849103296
-
Addressing the theoretical and clinical advantages of combination therapy with inhibitors of the renin-angiotensin-aldosterone system: Antihypertensive effects and benefits beyond BP control
-
Ferrario CM. Addressing the theoretical and clinical advantages of combination therapy with inhibitors of the renin-angiotensin-aldosterone system: antihypertensive effects and benefits beyond BP control. Life Sci. 2010;86(9-10):289-99.
-
(2010)
Life Sci
, vol.86
, Issue.9-10
, pp. 289-299
-
-
Ferrario, C.M.1
-
57
-
-
19644384705
-
Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2
-
DOI 10.1161/CIRCULATIONAHA.104.510461
-
Ferrario CM, Jessup J, Chappell MC, et al. Effect of angiotensin- converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005;111(20):2605-10. (Pubitemid 40740859)
-
(2005)
Circulation
, vol.111
, Issue.20
, pp. 2605-2610
-
-
Ferrario, C.M.1
Jessup, J.2
Chappell, M.C.3
Averill, D.B.4
Brosnihan, K.B.5
Tallant, E.A.6
Diz, D.I.7
Gallagher, P.E.8
-
58
-
-
83255175529
-
Chymase-dependent generation of angiotensin II from angiotensin-(1-12) in human atrial tissue
-
This study in human atrial tissue from patients undergoing heart surgery for the treatment of resistant atrial fibrillation created the underpinning for a pathogenic role of myocyte Ang-(1-12) as the principal source accounting for the role of Ang II in the generation of cardiac arrthymias. The studies include demonstration of chymase as the Ang-(1-12) converting enzyme in human atrial tissue
-
•• Ahmad S, Simmons T, Varagic J, et al. Chymase-dependent generation of angiotensin II from angiotensin-(1-12) in human atrial tissue. PLoS One. 2011;6(12):e28501. This study in human atrial tissue from patients undergoing heart surgery for the treatment of resistant atrial fibrillation created the underpinning for a pathogenic role of myocyte Ang-(1-12) as the principal source accounting for the role of Ang II in the generation of cardiac arrthymias. The studies include demonstration of chymase as the Ang-(1-12) converting enzyme in human atrial tissue.
-
(2011)
PLoS One
, vol.6
, Issue.12
-
-
Ahmad, S.1
Simmons, T.2
Varagic, J.3
-
59
-
-
84875370725
-
Chymase mediates angiotensin-(1-12) metabolism in normal human hearts
-
Extending the prior conclusions obtained in human disease atrial tissue, the study confirms that chymase is the sole enzyme accounting for Ang-(1-12) metabolism to Ang II directly
-
•• Ahmad S, Wei CC, Tallaj J, et al. Chymase mediates angiotensin-(1-12) metabolism in normal human hearts. J Am Soc Hypertens. 2013;7(2):128-36. Extending the prior conclusions obtained in human disease atrial tissue, the study confirms that chymase is the sole enzyme accounting for Ang-(1-12) metabolism to Ang II directly.
-
(2013)
J Am Soc Hypertens
, vol.7
, Issue.2
, pp. 128-136
-
-
Ahmad, S.1
Wei, C.C.2
Tallaj, J.3
-
60
-
-
0037214324
-
Chymase inhibitor improves survival in hamsters with myocardial infarction
-
Hoshino F, Urata H, Inoue Y, et al. Chymase inhibitor improves survival in hamsters with myocardial infarction. J Cardiovasc Pharmacol. 2003;41 Suppl 1:S11-8. (Pubitemid 36015026)
-
(2003)
Journal of Cardiovascular Pharmacology
, vol.41
, Issue.SUPPL. 1
-
-
Hoshino, F.1
Urata, H.2
Inoue, Y.3
Saito, Y.4
Yahiro, E.5
Ideishi, M.6
Arakawa, K.7
Saku, K.8
-
61
-
-
77951171609
-
Mast cell chymase limits the cardiac efficacy of Ang I-converting enzyme inhibitor therapy in rodents
-
Wei CC, Hase N, Inoue Y, et al. Mast cell chymase limits the cardiac efficacy of Ang I-converting enzyme inhibitor therapy in rodents. J Clin Invest. 2010;120(4):1229-39.
-
(2010)
J Clin Invest
, vol.120
, Issue.4
, pp. 1229-1239
-
-
Wei, C.C.1
Hase, N.2
Inoue, Y.3
-
62
-
-
0033770425
-
Hypothesis regarding the pathophysiological role of alternative pathways of angiotensin II formation in atherosclerosis
-
Arakawa K, Urata H. Hypothesis regarding the pathophysiological role of alternative pathways of angiotensin II formation in atherosclerosis. Hypertension. 2000;36(4):638-41.
-
(2000)
Hypertension
, vol.36
, Issue.4
, pp. 638-641
-
-
Arakawa, K.1
Urata, H.2
-
63
-
-
0033054630
-
Increased chymase-dependent angiotensin II formation in human atherosclerotic aorta
-
Ihara M, Urata H, Kinoshita A, et al. Increased chymase-dependent angiotensin II formation in human atherosclerotic aorta. Hypertension. 1999;33(6):1399-405. (Pubitemid 29282661)
-
(1999)
Hypertension
, vol.33
, Issue.6
, pp. 1399-1405
-
-
Ihara, M.1
Urata, H.2
Kinoshita, A.3
Suzumiya, J.4
Sasaguri, M.5
Kikuchi, M.6
Ideishi, M.7
Arakawa, K.8
-
64
-
-
79955490484
-
Blood glucose level and survival in streptozotocin-treated human chymase transgenic mice
-
Rafiq K, Sherajee SJ, Fan YY, et al. Blood glucose level and survival in streptozotocin-treated human chymase transgenic mice. Chin J Physiol. 2011;54(1):30-5.
-
(2011)
Chin J Physiol
, vol.54
, Issue.1
, pp. 30-35
-
-
Rafiq, K.1
Sherajee, S.J.2
Fan, Y.Y.3
-
65
-
-
0037017384
-
Evidence for a role of mast cells in the evolution to congestive heart failure
-
DOI 10.1084/jem.20002036
-
Hara M, Ono K, Hwang MW, et al. Evidence for a role ofmast cells in the evolution to congestive heart failure. J Exp Med. 2002;195(3):375-81. (Pubitemid 34461496)
-
(2002)
Journal of Experimental Medicine
, vol.195
, Issue.3
, pp. 375-381
-
-
Hara, M.1
Ono, K.2
Hwang, M.-W.3
Iwasaki, A.4
Okada, M.5
Nakatani, K.6
Sasayama, S.7
Matsumori, A.8
-
66
-
-
0038012831
-
Role for chymase in heart failure: Angiotensin II-dependent or -independent mechanisms?
-
DOI 10.1161/01.CIR.0000074786.92067.AA
-
Kokkonen JO, Lindstedt KA, Kovanen PT. Role for chymase in heart failure: angiotensin II-dependent or -independent mechanisms? Circulation. 2003;107(20):2522-4. (Pubitemid 36628925)
-
(2003)
Circulation
, vol.107
, Issue.20
, pp. 2522-2524
-
-
Kokkonen, J.O.1
Lindstedt, K.A.2
Kovanen, P.T.3
-
67
-
-
0037512313
-
Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure
-
DOI 10.1161/01.CIR.0000074041.81728.79
-
Matsumoto T, Wada A, Tsutamoto T, et al. Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure. Circulation. 2003;107(20):2555-8. (Pubitemid 36628935)
-
(2003)
Circulation
, vol.107
, Issue.20
, pp. 2555-2558
-
-
Matsumoto, T.1
Wada, A.2
Tsutamoto, T.3
Ohnishi, M.4
Isono, T.5
Kinoshita, M.6
-
68
-
-
0030662137
-
Angiotensin II formation from ACE and chymase in human and animal hearts: Methods and species considerations
-
Balcells E, Meng QC, Johnson Jr WH, et al. Angiotensin II formation from ACE and chymase in human and animal hearts: methods and species considerations. Am J Physiol. 1997;273(4 Pt 2): H1769-74.
-
(1997)
Am J Physiol
, vol.273
, Issue.4 PART 2
-
-
Balcells, E.1
Meng, Q.C.2
Johnson Jr., W.H.3
-
69
-
-
77958511663
-
Chymase inhibition prevents fibronectin andmyofibrillar loss and improves cardiomyocyte function and LV torsion angle in dogs with isolated mitral regurgitation
-
Pat B, Chen Y, Killingsworth C, et al. Chymase inhibition prevents fibronectin andmyofibrillar loss and improves cardiomyocyte function and LV torsion angle in dogs with isolated mitral regurgitation. Circulation. 2010;122(15):1488-95.
-
(2010)
Circulation
, vol.122
, Issue.15
, pp. 1488-1495
-
-
Pat, B.1
Chen, Y.2
Killingsworth, C.3
-
70
-
-
0033580595
-
Evidence for angiotensin-converting enzyme- and chymase-mediated angiotensin II formation in the interstitial fluid space of the dog heart in vivo
-
Wei CC, Meng QC, Palmer R, et al. Evidence for angiotensin-converting enzyme- and chymase-mediated angiotensin II formation in the interstitial fluid space of the dog heart in vivo. Circulation. 1999;99(19):2583-9. (Pubitemid 29228291)
-
(1999)
Circulation
, vol.99
, Issue.19
, pp. 2583-2589
-
-
Wei, C.-C.1
Meng, Q.C.2
Palmer, R.3
Hageman, G.R.4
Durand, J.5
Bradley, W.E.6
Farrell, D.M.7
Hankes, G.H.8
Oparil, S.9
Dell'Italia, L.J.10
-
71
-
-
0037623852
-
Cardiac interstitial bradykinin and mast cells modulate pattern of LV remodeling in volume overload in rats
-
Wei CC, Lucchesi PA, Tallaj J, et al. Cardiac interstitial bradykinin and mast cells modulate pattern of LV remodeling in volume overload in rats. Am J Physiol Heart Circ Physiol. 2003;285(2):H784-92. (Pubitemid 36885912)
-
(2003)
American Journal of Physiology - Heart and Circulatory Physiology
, vol.285
, Issue.2
-
-
Wei, C.-C.1
Lucchesi, P.A.2
Tallaj, J.3
Bradley, W.E.4
Powell, P.C.5
Dell'Italia, L.J.6
-
72
-
-
84863104638
-
Cardiac kallikrein-kinin system is upregulated in chronic volume overload and mediates an inflammatory induced collagen loss
-
Treatment of left heart valve insufficiency that leads to cardiac volume overload remains a formidable issue for which effective treatments are not available. In an experimental model of pure volume overload induced by the creation of an aorto-caval fistula, the authors demonstrate a significant contribution of the cardiac cellular kallikreinkinin system and beneficial effects of blockade with aprotinin
-
•• Wei CC, Chen Y, Powell LC, et al. Cardiac kallikrein-kinin system is upregulated in chronic volume overload and mediates an inflammatory induced collagen loss. PLoS One. 2012;7(6):e40110. Treatment of left heart valve insufficiency that leads to cardiac volume overload remains a formidable issue for which effective treatments are not available. In an experimental model of pure volume overload induced by the creation of an aorto-caval fistula, the authors demonstrate a significant contribution of the cardiac cellular kallikreinkinin system and beneficial effects of blockade with aprotinin.
-
(2012)
PLoS One
, vol.7
, Issue.6
-
-
Wei, C.C.1
Chen, Y.2
Powell, L.C.3
-
73
-
-
84886430857
-
Characterization of the cardiac renin angiotensin system in oophorectomized and estrogen-replete mRen2.Lewis rats
-
By exploring the role of estrogen on the cardiac renin angiotensin system, the authors demonstrate a beneficial action of this sex steroid in blocking cardiac chymase Ang II formation
-
• Wang H, Jessup JA, Zhao Z, et al. Characterization of the cardiac renin angiotensin system in oophorectomized and estrogen-replete mRen2.Lewis rats. PLoS One. 2013;8(10):e76992. By exploring the role of estrogen on the cardiac renin angiotensin system, the authors demonstrate a beneficial action of this sex steroid in blocking cardiac chymase Ang II formation.
-
(2013)
PLoS One
, vol.8
, Issue.10
-
-
Wang, H.1
Jessup, J.A.2
Zhao, Z.3
-
75
-
-
0030838414
-
Compartmentalization of angiotensin II generation in the dog heart: Evidence for independent mechanisms in intravascular and interstitial spaces
-
Dell'Italia LJ, Meng QC, Balcells E, et al. Compartmentalization of angiotensin II generation in the dog heart. Evidence for independent mechanisms in intravascular and interstitial spaces. J Clin Invest. 1997;100(2):253-8. (Pubitemid 27349070)
-
(1997)
Journal of Clinical Investigation
, vol.100
, Issue.2
, pp. 253-258
-
-
Dell'Italia, L.J.1
Meng, Q.C.2
Balcells, E.3
Wei, C.-C.4
Palmer, R.5
Hageman, G.R.6
Durand, J.7
Hankes, G.H.8
Oparil, S.9
-
76
-
-
0036023644
-
Dissecting the role of chymase in angiotensin II formation and heart and blood vessel diseases
-
DOI 10.1097/00001573-200207000-00009
-
Dell'Italia LJ, Husain A. Dissecting the role of chymase in angiotensin II formation and heart and blood vessel diseases. Curr Opin Cardiol. 2002;17(4):374-9. (Pubitemid 34864606)
-
(2002)
Current Opinion in Cardiology
, vol.17
, Issue.4
, pp. 374-379
-
-
Dell'Italia, L.J.1
Husain, A.2
-
77
-
-
0026510060
-
Cardiac actions of angiotensin II: Role of an intracardiac renin-angiotensin system
-
Baker KM, Booz GW, Dostal DE. Cardiac actions of angiotensin II: Role of an intracardiac renin-angiotensin system. Annu Rev Physiol. 1992;54:227-41.
-
(1992)
Annu Rev Physiol
, vol.54
, pp. 227-241
-
-
Baker, K.M.1
Booz, G.W.2
Dostal, D.E.3
-
78
-
-
0035106195
-
Different angiotensin II-forming pathways in human and rat vascular tissues
-
DOI 10.1016/S0009-8981(01)00379-5, PII S0009898101003795
-
Takai S, Sakaguchi M, Jin D, et al. Different angiotensin II-forming pathways in human and rat vascular tissues. Clin Chim Acta. 2001;305(1-2):191-5. (Pubitemid 32201977)
-
(2001)
Clinica Chimica Acta
, vol.305
, Issue.1-2
, pp. 191-195
-
-
Takai, S.1
Sakaguchi, M.2
Jin, D.3
Yamada, M.4
Kirimura, K.5
Miyazaki, M.6
-
79
-
-
66949181206
-
Alpha 2-macroglobulin capture allows detection of mast cell chymase in serum and creates a reservoir of angiotensin II-generating activity
-
Raymond WW, Su S, Makarova A, et al. Alpha 2-macroglobulin capture allows detection of mast cell chymase in serum and creates a reservoir of angiotensin II-generating activity. J Immunol. 2009;182(9):5770-7.
-
(2009)
J Immunol
, vol.182
, Issue.9
, pp. 5770-5777
-
-
Raymond, W.W.1
Su, S.2
Makarova, A.3
-
80
-
-
66249098883
-
Differential regulation of angiotensin-(1-12) in plasma and cardiac tissue in response to bilateral nephrectomy
-
Ferrario CM, Varagic J, Habibi J, et al. Differential regulation of angiotensin-(1-12) in plasma and cardiac tissue in response to bilateral nephrectomy. Am J Physiol Heart Circ Physiol. 2009;296(4):H1184-92.
-
(2009)
Am J Physiol Heart Circ Physiol
, vol.296
, Issue.4
-
-
Ferrario, C.M.1
Varagic, J.2
Habibi, J.3
-
81
-
-
44949253157
-
Angiotensin-(1-12) is an alternate substrate for angiotensin peptide production in the heart
-
Trask AJ, Jessup JA, Chappell MC, et al. Angiotensin-(1-12) is an alternate substrate for angiotensin peptide production in the heart. Am J Physiol Heart Circ Physiol. 2008;294(5):H2242-7.
-
(2008)
Am J Physiol Heart Circ Physiol
, vol.294
, Issue.5
-
-
Trask, A.J.1
Jessup, J.A.2
Chappell, M.C.3
-
82
-
-
33751094865
-
Intracellular angiotensin II induces cell proliferation independent of AT1 receptor
-
Baker KM, Kumar R. Intracellular angiotensin II induces cell proliferation independent of AT1 receptor. Am J Physiol Cell Physiol. 2006;291(5):C995-1001.
-
(2006)
Am J Physiol Cell Physiol
, vol.291
, Issue.5
-
-
Baker, K.M.1
Kumar, R.2
-
83
-
-
33751291204
-
Volume-overload cardiac hypertrophy is unaffected by ACE inhibitor treatment in dogs
-
Dell'Italia LJ, Balcells E, Meng QC, et al. Volume-overload cardiac hypertrophy is unaffected by ACE inhibitor treatment in dogs. Am J Physiol. 1997;273(2 Pt 2):H961-70.
-
(1997)
Am J Physiol
, vol.273
, Issue.2 PART 2
-
-
Dell'Italia, L.J.1
Balcells, E.2
Meng, Q.C.3
-
84
-
-
41749123049
-
Activation of the intracellular renin-angiotensin system in cardiac fibroblasts by high glucose: Role in extracellular matrix production
-
DOI 10.1152/ajpheart.91493.2007
-
Singh VP, Baker KM, Kumar R. Activation of the intracellular renin-angiotensin system in cardiac fibroblasts by high glucose: role in extracellular matrix production. Am J Physiol Heart Circ Physiol. 2008;294(4):H1675-84. (Pubitemid 351490598)
-
(2008)
American Journal of Physiology - Heart and Circulatory Physiology
, vol.294
, Issue.4
-
-
Singh, V.P.1
Baker, K.M.2
Kumar, R.3
-
85
-
-
0024549047
-
Direct formation of angiotensin II without renin or converting enzyme in the ischemic dog heart
-
Gondo M, Maruta H, Arakawa K. Direct formation of angiotensin II without renin or converting enzyme in the ischemic dog heart. Jpn Heart J. 1989;30(2):219-29. (Pubitemid 19104461)
-
(1989)
Japanese Heart Journal
, vol.30
, Issue.2
, pp. 219-229
-
-
Gondo, M.1
Maruta, H.2
Arakawa, K.3
-
86
-
-
0023872912
-
Formation of angiotensin II by tonin-inhibitor complex
-
Ikeda M, Sasaguri M, Maruta H, et al. Formation of angiotensin II by tonin-inhibitor complex. Hypertension. 1988;11(1):63-70. (Pubitemid 18086312)
-
(1988)
Hypertension
, vol.11
, Issue.1
, pp. 63-70
-
-
Ikeda, M.1
Sasaguri, M.2
Maruta, H.3
Arakawa, K.4
-
87
-
-
0019830180
-
A human neutrophil-dependent pathway for generation of angiotensin II: Purification and physicochemical characterization of the plasma protein substrate
-
DOI 10.1073/pnas.78.2.1204
-
Wintroub BU, Klickstein LB, Kaempfer CE, et al. A human neutrophil-dependent pathway for generation of angiotensin II: purification and physicochemical characterization of the plasma protein substrate. Proc Natl Acad Sci U S A. 1981;78(2):1204-8. (Pubitemid 11102189)
-
(1981)
Proceedings of the National Academy of Sciences of the United States of America
, vol.78
, Issue.2 II
, pp. 1204-1208
-
-
Wintroub, B.U.1
Klickstein, L.B.2
Kaempfer, C.E.3
Austen, K.F.4
-
88
-
-
0021369489
-
Granulocyte-angiotensin system. Identification of angiotensinogen as the plasma protein substrate of leukocyte cathepsin G
-
Wintroub BU, Klickstein LB, Dzau VJ, et al. Granulocyte-angiotensin system. Identification of angiotensinogen as the plasma protein substrate of leukocyte cathepsin G. Biochemistry. 1984;23(2):227-32. (Pubitemid 14185166)
-
(1984)
Biochemistry
, vol.23
, Issue.2
, pp. 227-232
-
-
Wintroub, B.U.1
Klickstein, L.B.2
Dzau, V.J.3
Watt, K.W.K.4
-
89
-
-
79251527249
-
Angiotensinogen metabolism in rat aorta: Robust formation of proangiotensin-12
-
Bujak-Gizycka B, Olszanecki R, Suski M, et al. Angiotensinogen metabolism in rat aorta: robust formation of proangiotensin-12. J Physiol Pharmacol. 2010;61(6):679-82.
-
(2010)
J Physiol Pharmacol
, vol.61
, Issue.6
, pp. 679-682
-
-
Bujak-Gizycka, B.1
Olszanecki, R.2
Suski, M.3
-
90
-
-
84891455879
-
Renin does not participate in the production of plasma angiotensin-(1-12) from angiotensinogen
-
Simington SW, Moniwa N, Ahmad S, VonCannon J, Dell Italia LJ, Varagic J, et al. Renin does not participate in the production of plasma angiotensin-(1-12) from angiotensinogen. Hypertension. 2012;60:A628.
-
(2012)
Hypertension
, vol.60
-
-
Simington, S.W.1
Moniwa, N.2
Ahmad, S.3
VonCannon, J.4
Dell Italia, L.J.5
Varagic, J.6
-
91
-
-
0017225506
-
A pressor formation by trypsin from renin-denatured human plasma protein
-
Arakawa K, Ikeda M, Fukuyama J, et al. A pressor formation by trypsin from renin-denatured human plasma protein. J Clin Endocrinol Metab. 1976;42(3):599-602.
-
(1976)
J Clin Endocrinol Metab
, vol.42
, Issue.3
, pp. 599-602
-
-
Arakawa, K.1
Ikeda, M.2
Fukuyama, J.3
-
92
-
-
0019127132
-
Ability of kallikrein to generate angiotensin II like pressor substance and a proposed 'kinin-tensin enzyme system'
-
DOI 10.1038/288705a0
-
Arakawa K, Maruta H. Ability of kallikrein to generate angiotensin II-like pressor substance and a proposed 'kinin-tensin enzyme system'. Nature. 1980;288(5792):705-6. (Pubitemid 11168524)
-
(1980)
Nature
, vol.288
, Issue.5792
, pp. 705-706
-
-
Arakawa, K.1
Maruta, H.2
|